Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Minqiang Lu"'
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Purpose Hepatocellular carcinoma (HCC) associated with Hepatitis B Virus (HBV) is one of the most severe malignancies in East Asia, where early diagnosis is crucial for improving patient prognosis. So we aim to identify effective early diagn
Externí odkaz:
https://doaj.org/article/edfd9b6a8cf94890bbd3844d0e28f630
Autor:
Linyu Pan, Ze Yu, Xiaolin Liang, Jiyou Yao, Yanfang Fu, Xu He, Xiaoling Ren, Jiajia Chen, Xuejuan Li, Minqiang Lu, Tian Lan
Publikováno v:
Hepatology Communications, Vol 7, Iss 2, Pp e0039-e0039 (2023)
Non-alcoholic steatohepatitis (NASH) has become a major cause of liver transplantation and liver-associated death. The gut-liver axis is a potential therapy for NASH. Sodium cholate (SC) is a choleretic drug whose main component is bile acids and has
Externí odkaz:
https://doaj.org/article/315354539c4249d9a1bd552c84868735
Autor:
Shaotao Jiang, Rongdang Fu, Jiewei Shi, Huijie Wu, Jialuo Mai, Xuefeng Hua, Huan Chen, Jie Liu, Minqiang Lu, Ning Li
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Angiogenesis is necessary for carcinoma progression and is regulated by a variety of pro- and anti-angiogenesis factors. CircRNAs are RNA molecules that do not have a 5’-cap or a 3’-polyA tail and are involved in a variety of biological functions
Externí odkaz:
https://doaj.org/article/e2685b9b80fd4a21a06b32d503fcb71d
Autor:
Shaotao Jiang, Huijie Wu, Rongdang Fu, Jialuo Mai, Jiyou Yao, Xuefeng Hua, Huan Chen, Jie Liu, Minqiang Lu, Ning Li
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundPrimary hepatic carcinoid tumor (PHCT) is rare and has unclear clinical characteristics and prognosis.MethodsA retrospective study using data from the SEER database for patients diagnosed with PHCT used univariate and multivariate Cox model
Externí odkaz:
https://doaj.org/article/be348ef2225f459d90d2ea00a65f0602
Publikováno v:
Combinatorial Chemistry & High Throughput Screening. 26
Introduction: Cervical cancer is one of the malignant cancers with high mortality among women worldwide. Although vaccines and early detection have reduced cervical cancer mortality, it remains a malignancy with a high mortality rate in women. Object
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da76bddc4bd80ba5e7d8998c03ba62f6
https://doi.org/10.2174/1386207326666230504124030
https://doi.org/10.2174/1386207326666230504124030
Autor:
Jin Lv, Jiyou Yao, Jie Liu, Xuefeng Hua, Minqiang Lu, Rongdang Fu, Jialuo Mai, Huan Chen, Ning Li, Shaotao Jiang
Publikováno v:
Biomarkers in Medicine. 15:347-358
Background: Recent studies have shown that cleavage and polyadenylation-specific factor 3 (CPSF3) is a promising antitumor therapeutic target, but its potential role in hepatocellular carcinoma (HCC) has not been reported. Materials & methods: We exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84aaba491ce5ce28c19b639b00c56611
https://doi.org/10.2217/bmm-2021-0039
https://doi.org/10.2217/bmm-2021-0039
Publikováno v:
European Journal of Surgical Oncology. 47:690-698
Hepatic angiosarcoma(HAS) is rare and is the primary vascular-derived malignancy of the liver. Its clinical characteristics, therapeutic strategy management, and the outcome are unclear.This is a retrospective study of patients from the SEER database
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1fd27404871d50bfeee1a58173be370
https://doi.org/10.1016/j.ejso.2020.11.121
https://doi.org/10.1016/j.ejso.2020.11.121
Publikováno v:
Genomics Data, Vol 4, Iss C, Pp 93-95 (2015)
To assess the potential competitive endogenous RNA (ceRNA) network in hepatocellular cancer (HCC), the lncRNA, mRNA, and microRNA microarrays were conducted on 3 pairs of HCC and paired normal liver tissue. After that, the arrays were normalized and
Externí odkaz:
https://doaj.org/article/6f1bf9766ff24b07805e8e5ed25c4f5f
Publikováno v:
Translational Cancer Research
Background Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and the third leading cause of cancer-related death. MicroRNAs and transcription factors (TFs) cooperate to regulate the same target gene, thus affecting the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c45cf1beddc08b1eec8d567ead551e5
https://doi.org/10.21037/tcr-20-686
https://doi.org/10.21037/tcr-20-686
Autor:
Jiyou Yao, Xuefeng Hua, Jiewei Shi, Xiaoyuan Hu, Kayin Lui, Kaitao He, Jialuo Mai, Tian Lan, Minqiang Lu
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental BiologyREFERENCES. 36(4)
Hepatocellular carcinoma (HCC) is a major challenge for human health. Finding reliable diagnostic biomarkers and therapeutic targets for HCC is highly desired in the clinic. Currently, circulating exosomal lncRNA is a promising biomarker for the diag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3abbdb73637e8fa1a6cbdd3cb1eca883
https://pubmed.ncbi.nlm.nih.gov/35224785
https://pubmed.ncbi.nlm.nih.gov/35224785